Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes.

Source:http://linkedlifedata.com/resource/pubmed/id/15073134

Clin. Cancer Res. 2004 Apr 1 10 7 2538-44

Download in:

View as

General Info

PMID
15073134